OVERVIEW

Optimizing Clinical Outcomes by Optimizing the Management of Hyperlipidemia is organized by C3-Interventional Academy.

Release Date: Oct 23, 2019
Expiration Date: Oct 23, 2020

Accreditation:
Ciné-Med assigns this enduring online CME material for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians can acquire credit commensurate based on the extent of their participation in the conference.

Educational Objectives:
At the conclusion of this online CME session, learners should be able to:
• specify the relationship between LDL-C and cardiovascular disease as well as the substantial residual risk among patients receiving statin therapy.
• Discuss PCSK9 inhibition as a unique mechanism to reduce LDL-C and improve cardiovascular outcomes.
• Know the influence of PCSK9 inhibitors on coronary plaque, clinical outcomes, and safety, in particular neurocognitive events.
• Explain recent ACC/AHA guidelines for the management of hyperlipidemia in the context of clinical cases.

Additional details will be posted as soon as information is available.

SPECIALITIES

Cardiology

TERMS & CONDITIONS

 

RELATED ONLINE COURSES

Illinois Nurse Practitioners State Board required courses bundle
Jul 14, 2021 - Jun 22, 2025 | Webcast
State required course for Illinois
4 AMA PRA Category 1 Credit™ ...
More actions
US$470
Ohio Nurse Practitioners State Board required courses bundle
Jul 14, 2021 - Jun 22, 2025 | Webcast
State required course for Ohio
12 Contact Hours
More actions
US$470
Virginia Physicians Primary Care and Internal Medicine Courses Bundle
Mar 16, 2022 - Jun 26, 2024 | Webcast
General Practice
26.25 AMA PRA Category 1 Credit™ ...
More actions
US$616.80